Drug repurposing is recently gaining increasing attention, not just from pharmaceutical
companies but also from government agencies in an attempt to generate new medications to …

Identifying effective disease-modifying therapies for neurological diseases remains an
important challenge in drug discovery and development. Drug repurposing attempts to …

Parkinson's disease is a highly disabling, progressive neurodegenerative disease that
manifests as a mix of motor and non‐motor signs. Although we are equipped with some …

Alzheimer's disease (AD) is the most common cause of dementia and a major cause of
morbidity and mortality. The greatest risk factor for AD is age and as many countries are …

Neurodegenerative diseases are increasing in number, given that the general global
population is becoming older. They manifest themselves through mechanisms that are not …

Repurposing drugs requires finding novel therapeutic indications compared to the ones for
which they were already approved. This is an increasingly utilized strategy for finding novel …

As a long-term degenerative disorder of the central nervous system that mostly affects older
people, Parkinson's disease is a growing health threat to our ever-aging population. Despite …

Alzheimer's disease (AD) is a complex neurodegenerative condition that is characterized by
the build-up of amyloid-beta plaques and neurofibrillary tangles. While multiple theories …

Neurodegenerative diseases (ND) are of vast origin which are characterized by gradual
progressive loss of neurons in the brain region. ND can be classified according to the …

The unmet need for the development of effective drugs to treat Alzheimer's disease has
been steadily growing, representing a major challenge in drug discovery. In this context …